Quantcast

Latest Oncology Stories

2014-09-17 04:20:02

Tokyo, Sept 17, 2014 - (JCN Newswire) - Eisai Co., Ltd. announced today that a series of abstracts highlighting the latest clinical data on Halaven(R) (generic name: eribulin mesylate; non-taxane microtubule dynamics inhibitor, "Halaven") and lenvatinib mesylate (generic name; selective inhibitor of receptor tyrosine kinases (RTKs) with a novel binding mode, "lenvatinib") will be presented during the 39th European Society for Medical Oncology (ESMO) Congress...

2014-09-17 00:20:34

Article in Baltimore Sun WASHINGTON, Sept. 16, 2014 /PRNewswire-USNewswire/ -- George Washington University cancer researcher Dr. Patricia Berg, former White House Drug Policy Spokesman and House Aging Committee Director Robert Weiner, and Solutions for Change Senior Policy Analyst Tom Sherman, are asserting that Federal cancer research funding cuts are threatening the nation's mortality rate. The trio wrote an article, "FUND CANCER RESEARCH TO KEEP BREAKTHROUGHS COMING," which...

2014-09-16 23:16:55

Smith & Jones Developed Lung Cancer Screening Campaign for Ellis Medicine Troy, NY (PRWEB) September 16, 2014 More women die from lung cancer than breast, ovarian and cervical cancers combined, and lung cancer claims more lives of men than any other cancer. Ellis Medicine hopes to change the conversation surrounding lung cancer with a new community wellness campaign developed by healthcare marketing agency Smith & Jones. This multi-media campaign, which launched last month,...

2014-09-16 20:27:26

St. Jude Children's Research Hospital study has identified the cumulative dose of a widely used class of chemotherapy drugs that leaves young male cancer patients at risk for impaired sperm production as adults MEMPHIS, Tenn., Sept. 16, 2014 /PRNewswire-USNewswire/ -- A study led by St. Jude Children's Research Hospital investigators has found the chemotherapy dose threshold below which male childhood cancer survivors are likely to have normal sperm production. The study appears in...

2014-09-16 08:31:38

WASHINGTON, Sept. 16, 2014 /PRNewswire/ -- The Mesothelioma Victims Center is incredibly passionate about compensation for individuals diagnosed with this asbestos exposure form of cancer, especially if they live in New Jersey, New York, or Pennsylvania, and they offer victims, in these states instant access to the nation's most skilled mesothelioma attorneys, who are also among the leaders in mesothelioma compensation nationwide. If a diagnosed victim of mesothelioma does not want to...

2014-09-16 08:29:16

BOTHELL, Wash. and VANCOUVER, B.C., Sept.16, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that patient enrollment has been completed in the Phase 3 AFFINITY trial. The international, randomized, open-label Phase 3 AFFINITY trial is designed to evaluate the potential of custirsen to improve survival outcomes in approximately 630 men with metastatic castrate-resistant prostate cancer (CRPC). Patients have been randomized to receive second-line...

2014-09-16 04:21:18

WHIPPANY, N.J., Sept. 16, 2014 /PRNewswire/ -- Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral androgen receptor inhibitor in clinical development. The study, called ARAMIS, evaluates ODM-201 in men with castration-resistant prostate cancer who have rising Prostate Specific Antigen (PSA) levels and no detectable metastases. The trial is designed to...

2014-09-15 23:11:36

A collaborative study between researchers at the University of Colorado Cancer Center and the National Cancer Institute (NCI) published today in the journal Clinical Cancer Research takes an important step toward answering the question: which altered genes are most to blame for bladder cancer? AURORA, Colo. (PRWEB) September 15, 2014 The story of cancer care seems so simple: find the mutated gene that causes cancer and turn it off or fix it. But rarely does a single gene cause cancer....

2014-09-15 23:08:09

The results of a new Italian study suggest that it can take decades for an asbestos ban to have a major impact on the incidence of malignant pleural mesothelioma. Raleigh, NC (PRWEB) September 15, 2014 Researchers in Italy say the asbestos ban instituted by the country in 1992 has yet to have an observable impact on the number of people developing mesothelioma. Click here to read a new article on the research on the Surviving Mesothelioma website. Scientists with the Local Health...

2014-09-15 20:22:10

Data presented at American Society for Radiology (ASTRO) Annual Meeting in San Francisco SAN FRANCISCO, Sept. 15, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced data from two new studies presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting demonstrate the ability of its Decipher® Prostate Cancer Classifier, a genomic test capable of predicting aggressiveness of prostate cancer, to influence treatment decisions and improve patient outcomes for...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related